论文部分内容阅读
目的 :分析在小儿反复发作性过敏性紫癜患者治疗中,孟鲁司特钠的临床疗效。方法 :选取我院于2014年1月至2015年1月收治的50例小儿反复发作性过敏性紫癜患者为对象,将其随机均分为对照组与观察组,对照组患儿接受常规治疗,观察组患儿在此基础上联合接受孟鲁司特钠治疗,对比两组患儿临床疗效。结果 :观察组患儿的临床治疗效果明显好于对照组,两组患儿的数据经对比后存在统计学差异(P<0.05)。结论 :在小儿反复发作性过敏性紫癜患者治疗中,孟鲁司特钠的治疗效果较好,值得应用。
Objective: To analyze the clinical efficacy of montelukast sodium in the treatment of recurrent anaphylactoid purpura in children. Methods: Fifty cases of recurrent anaphylactoid purpura in our hospital from January 2014 to January 2015 were randomly divided into control group and observation group. The control group received routine treatment, On the basis of this observation, children in the observation group received montelukast sodium, comparing the clinical efficacy of the two groups. Results: The clinical efficacy of the observation group was significantly better than that of the control group. There was significant difference between the two groups (P <0.05). Conclusion: Montelukast sodium is effective in the treatment of recurrent anaphylactoid purpura in children and is worthy of application.